Attention Deficit Disorder (ADHD)



Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Methylphenidate LA (Ritalin);   Drug: Mixed Amphetamine Salts XR (Adderall)
Sponsors:   Massachusetts General Hospital;   Massachusetts Institute of Technology
Not yet recruiting - verified May 2017


Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: Immediate-release Methylphenidate
Sponsors:   Hospital de Clinicas de Porto Alegre;   Federal University of Rio Grande do Sul;   Conselho Nacional de Desenvolvimento Científico e Tecnológico;   Coordination for the Improvement of Higher Education Personnel
Recruiting - verified October 2016


Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: cognitive behavior group therapy;   Other: Treatment as usual
Sponsors:   St. Olavs Hospital;   Norwegian University of Science and Technology
Recruiting - verified January 2017


Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Behavioral: Cognitive-behavioral therapy
Sponsor:   Karolinska Institutet
Recruiting - verified August 2016


A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   Aevi Genomic Medicine
Completed - verified February 2017


Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: mazindol
Sponsor:   NLS-1 Pharma Inc.
Completed - verified April 2017


Early Interventions in Children With Attention Deficit/Hyperactivity Disorder


Conditions:   Attention Deficit Disorder With Hyperactivity;   Preschool Child
Interventions:   Drug: Methylphenidate;   Behavioral: Parental training;   Other: Psychoeducational groups for parents;   Drug: Placebo pill
Sponsors:   University of Sao Paulo;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified May 2017


Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder


Condition:   Attention Deficit-Hyperactivity Disorder
Interventions:   Device: Neurofeedback NFT;   Drug: Methylphenidate MPH
Sponsors:   Mensia Technologies SA;   European Union H2020 SME Instrument
Recruiting - verified April 2017


A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.


Condition:   Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: dasotraline 4mg;   Other: Placebo
Sponsor:   Sunovion
Completed - verified March 2017


Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children


Conditions:   Traumatic Brain Injury;   Attention Deficit Disorder
Interventions:   Drug: Lisdexamfetamine;   Drug: Placebo
Sponsors:   Vanderbilt University;   Shire
Recruiting - verified February 2017


Brain Training in Children With/At-risk for Attention-Deficit/Hyperactivity Disorder and Executive Function Impairment


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Brain Training (Active);   Behavioral: Brain Training (Passive);   Behavioral: Brain Training (Active or Passive)
Sponsor:   Stanford University
Recruiting - verified October 2016


Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Methylphenidate (MPH);   Drug: Atomoxetine
Sponsor:   Asan Medical Center
Recruiting - verified July 2016


The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder


Condition:   Attention Deficit Disorder
Interventions:   Device: SR-HLAB EMG;   Drug: Methylphenidate
Sponsors:   HaEmek Medical Center, Israel;   Technion, Israel Institute of Technology
Active, not recruiting - verified August 2016


Genetic, Brain Structure, and Environmental Effects on ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified March 3, 2017


Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:  
Sponsors:   NHS Tayside;   Zentralinstitut für Seelische Gesundheit Mannheim;   Universita degli Studi di Cagliari;   Vadaskert Child and Adolescent Psychiatric Hospital
Completed - verified September 2016


Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits


Conditions:   Traumatic Brain Injury;   Attention Deficit Disorder
Interventions:   Drug: Vyvanse;   Procedure: fMRI;   Drug: Placebo
Sponsors:   Vanderbilt University;   Shire
Terminated - verified April 2017


Comparing School Based Interventions for Adolescents With Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: Challenging Horizons Program (CHP) after-school model;   Behavioral: Challenging Horizons Program (CHP) consultation model
Sponsors:   Children's Hospital Medical Center, Cincinnati;   National Institute of Mental Health (NIMH)
Completed - verified December 2016


Reducing Attention Deficit Hyperactivity Disorder in Kindergarten and Pre-Kindergarten Children


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: Friendship Group;   Behavioral: Academic tutoring
Sponsors:   Penn State University;   National Institute of Mental Health (NIMH)
Completed - verified March 2017


International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit/Hyperactivity Disorder
Interventions:   Drug: Short Acting Methylphenidate;   Drug: Long Acting Methylphenidate
Sponsor:   BRC Operations Pty. Ltd.
Recruiting - verified July 2016


Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison


Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Strattera
Sponsor:   Norwegian University of Science and Technology
Completed - verified April 2017


Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: Meta-Cognitive Therapy;   Behavioral: Supportive Therapy
Sponsors:   Icahn School of Medicine at Mount Sinai;   National Institute of Mental Health (NIMH)
Completed - verified February 2017


Treatment of Patients With Alcoholism and Attention Deficit Disorder


Conditions:   Alcoholism;   Attention Deficit Disorder
Intervention:   Drug: Methylphenidate
Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Completed - verified April 9, 2007


Safety of SPD465 in Treating Adults With ADHD.


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.
Sponsor:   Shire
Completed - verified January 2017


Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Methylphenidate 0.15 mg/kg;   Behavioral: Low-Intensity BMOD;   Drug: Methylphenidate 0.3 mg/kg;   Drug: Placebo;   Drug: Methylphenidate 0.6 mg/kg;   Behavioral: High Intensity BMOD
Sponsors:   Florida International University;   National Institute of Mental Health (NIMH)
Completed - verified August 2016


Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Completed - verified January 30, 2017

Refine Your Search Advanced Search